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ABSTRACT: The Pictet−Spengler reaction is a valuable route to
1,2,3,4-tetrahydro-β-carboline (THBC) and isoquinoline scaffolds
found in many important pharmaceuticals. Strictosidine synthase
(STR) catalyzes the Pictet−Spengler condensation of tryptamine and
the aldehyde secologanin to give (S)-strictosidine as a key intermediate
in indole alkaloid biosynthesis. STRs also accept short-chain aliphatic
aldehydes to give enantioenriched alkaloid products with up to 99% ee
STRs are thus valuable asymmetric organocatalysts for applications in
organic synthesis. The STR catalysis of reactions of small aldehydes
gives an unexpected switch in stereopreference, leading to formation of
the (R)-products. Here we report a rationale for the formation of the
(R)-configured products by the STR enzyme from Ophiorrhiza pumila (OpSTR) using a combination of X-ray crystallography,
mutational, and molecular dynamics (MD) studies. We discovered that short-chain aldehydes bind in an inverted fashion compared
to secologanin leading to the inverted stereopreference for the observed (R)-product in those cases. The study demonstrates that the
same catalyst can have two different productive binding modes for one substrate but give different absolute configuration of the
products by binding the aldehyde substrate differently. These results will guide future engineering of STRs and related enzymes for
biocatalytic applications.
■ INTRODUCTION
Isoquinoline and β-carboline derivatives are both widespread
structural motifs found in alkaloids isolated from various plants
and animals. The isoquinoline scaffold is a building block of
many pharmaceutically important drugs such as the anti-
spasmodic papaverine and the analgesic codeine.1 β-Carboline
alkaloids exhibit a wide range of psychopharmacological effects
through inhibition of monoamine oxidases or by binding to
benzodiazepine receptors.2
The Pictet−Spengler reaction, by which 1,2,3,4-tetrahydro-
β-carbolines (THBCs) and isoquinolines are synthesized from
amines and aldehydes, represents an important synthetic
procedure for the preparation of alkaloid derivatives and
pharmaceuticals since its discovery more than a century ago.3
The development of asymmetric synthetic versions of the
reaction has sparked great interest. In addition to diaster-
eoselective approaches, where stereocontrol can be exerted by
either the amine4 or the carbonyl substrate,5 using a chiral
auxiliary,6 several procedures employing chiral catalysts, such
as Bronsted acids,7 Lewis acids,8 or thiourea compounds,9 have
also been described in literature.
In nature, the equivalent reaction is catalyzed by enzymes
known as “Pictet−Spenglerases” (PSases). Since the identi-
fication of the first PSase in 197610 this enzyme family has
been constantly growing. In addition to the well-investigated
representatives norcoclaurine synthase (NCS)11 and strictosi-
dine synthase (STR), many PSases, such as deacetylipecoside
synthase (DIS) and deacetylisoipecoside synthase (DIIS) from
Alangium lamarckii,12 SfmC-C from Streptomyces lavendulae,13
McbB from Marinactinospora thermotolerans,14 and NscbB
(from Nocardiopsis synnemataformans DSM 44143),15 have
been identified; however, structural, mechanistic, or biosyn-
thetic applications of the latter have not been intensively
studied.
The first identified representative of “Pictet−Spenglerases”,
STR from Rauvolf ia serpentina (RsSTR, EC 4.3.3.2), catalyzes
the stereoselective condensation of tryptamine (1) and
secologanin, leading to the formation of (S)-strictosidine, a
central intermediate in the biosynthetic pathway of indole
alkaloids (Scheme 1A).16 Crystal structures of RsSTR and
mechanistic studies revealed that the reaction is catalyzed by a
glutamate residue, Glu309, in the active site pocket, likely
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assisted by neighboring tyrosine and histidine.17 Evaluation of
the synthetic potential of this and other STRs revealed a
relatively broad applicability of various tryptamine analogues as
substrates.17c,18 In addition to secologanin analogues,18c,19
selected aldehydes bearing shorter side chains were accepted
by the enzyme, although with lower activities.20 However,
interestingly, we discovered that for small aliphatic aldehydes
(e.g., 2a−d) the corresponding (R)-configured THBC
products were obtained employing, for example, the STR
from Ophiorrhiza pumila (OpSTR) or RsSTR with an ee of
>98% for 3a (Scheme 1B), in contrast to the absolute
configuration of the natural (S)-configured product (S)-
strictosidine.20b
We have now investigated the origin of this switch in
stereopreference from (S) for the natural reaction (tryptamine
with secologanin) to (R) when using non-native aldehydes
2a−d as substrates with tryptamine employing the STR from
Ophiorrhiza pumila (OpSTR). We use X-ray crystallography,
mutational analysis, and MD simulations to determine the
origin of this unexpected phenomenon.
■ RESULTS AND DISCUSSION
In a first attempt to elucidate the origin of the (R)-
stereoselectivity of OpSTR with aldehydes 2b−d (Scheme
1B), X-ray crystallographic studies were performed with
OpSTR cocrystallized with racemic THBC products 3a−c as
ligands. The overall architecture of OpSTR is a six-bladed β-
propeller fold (Figure 1), as previously observed in crystal
structures of related enzymes such as RsSTR. Here each blade
consists of a four-stranded antiparallel β-sheet arranged around
a central axis. The individual strands are twisted, resulting in an
almost perpendicular orientation of the fourth strand to the
first inner strand. One of these β-sheets (β-sheet 1, Figure 1) is
formed from one strand from the N-terminus and three strands
from the C-terminus, forming the so-called “velcro closure”
present in most β-propeller proteins. Additionally, four short
α-helices located at the outer surface of the propeller are
present in the structure of OpSTR. One of these helices
situated on top of the central axis of the enzyme forms the
entrance to the active site pocket. Two of these helices are
connected by a conserved disulfide bridge formed between
residues Cys60 and Cys72 in OpSTR (numbering of residues is
adapted to the amino acid sequence devoid of a N-terminal
signal peptide that is removed for improved expression20b).
Soaking experiments with apo-crystals of OpSTR with
THBCs were unsuccessful. However, OpSTR readily cocrystal-
lized in the presence of racemic THBCs rac-3a−c and yielded
diffracting crystals with the corresponding ligand coordinated
in the active site pocket. In the observed orientation of ligand 3
in the active site, the aliphatic substituent of the THBCs
(isobutyl for 3a) points into the active site pocket; thus, the β-
carboline is pointing outside. This is in contrast to the
structures of STR from Rauvolf ia serpentina with the natural
product (S)-strictosidine (PDB code: 2v91), where the β-
carboline points into the active site pocket and the aldehyde
side chain protrudes from the active site. Despite the switched
orientation of the molecule, the position of the nitrogen atom
of the indole moiety of the ligands (S)-strictosidine and 3a is
similar and in close proximity to the active site glutamate
residue (Glu309 in RsSTR, Glu276 in OpSTR; Figure 2A). All
ligands found in crystal structures determined from cocrystal-
lization experiments with racemic THBCs (3a−c) adopted a
similar orientation in the active site (Figure 2B). The distances
from the N atom to Glu276 found in the crystal structures
range between 2.8 Å (structure with 3b) and 3.6 Å (structure
with 3c). The most surprising finding however was that in all
cases exclusively the (S)-enantiomers of 3a−c were identified
in the active site of OpSTR, which represents the opposite
enantiomer of the preferred (R)-product formed in the
corresponding enzymatic reactions. However, no crystals
were formed when using optically pure (R)-3a, which is
produced by the enzyme with >98% ee, as ligand for
cocrystallization,
Because the obtained crystal structures contained the (S)-
and not the expected (R)-enantiomers, it was suspected that
the (S)-THBC may act as inhibitor, due to the higher affinity
Scheme 1. Reactions Catalyzed by Strictosidine Synthase
(STR)b
aResults published previously.20b bA: natural reaction of tryptamine
with secologanin yielding (S)-strictosidine; B: reactions between
tryptamine and small aliphatic aldehydes 2a−d resulted in the
formation of the corresponding (R)-configured tetrahydro-β-carbo-
lines 3.
Figure 1. Overlay of structures of OpSTR (blue) and RsSTR (gray,
PDB 2v91). Residues mentioned in this paper are highlighted in cyan.
Ligands are not displayed.
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of this enantiomer to the enzyme. Indeed, when testing the
OpSTR in a reaction between 1 and 2a adding (S)-, (R)-, or
rac-3d, the IC50 values calculated from experimentally
determined reaction rates indicate that 3d has inhibitory
effects on OpSTR (Table 1).
While the (S)-enantiomer (S)-3d led to inhibition of the
reaction already at low concentration, the mirror image (R)-3d
led to inhibition only at higher concentrations. Thus, product
inhibition is mainly caused by the (S)-enantiomer. On the
basis of this observation, we concluded that the crystal
structures obtained most likely did not show the product
ligand in a catalytically productive conformation but rather
revealed the inhibition of the enzyme by (S)-THBCs.
Despite the acquisition of the OpSTR structures, the ligand
complexes did not provide information on the binding mode of
(R)-THBCs and thus did not explain the observed stereo-
preference. To gain more insight into the basis for selective
transformation by OpSTR, a stable amine mimic 4 of the imine
intermediate int-I formed from tryptamine and isobutyralde-
hyde 2a was designed (Figure 3). In the structure of OpSTR
obtained by cocrystallization with 4, two ligand molecules were
found in each protein monomer. The active site was occupied
by one ligand, while another ligand was bound to the periphery
of the enzyme (Figure 3). In the peripheral site, the amine
nitrogen was approximately 3.0 Å from the side chain of Glu6,
but mutation of this residue to alanine gave a mutant with
activity comparable to the wild type, suggesting that this is not
a secondary active site. In contrast, the Glu276Ala variant was
not active, showing that this is the residue responsible for
activity. In the active site, the aliphatic side chain of 4 was
pointing into the active site pocket, while the indole moiety
Figure 2. OpSTR and RsSTR with THBCs as ligands. (A) Comparison of OpSTR (blue) containing 3a (orange) with RsSTR (gray mesh)
containing (S)-strictosidine (gray, PDB: 2V91). (B) Alignment of different THBC ligands coordinated in OpSTR. The active site glutamate Glu276
coordinating the N atom is displayed as stick representation. The ligands are depicted in the following colors: 3a, orange; 3b, yellow; 3c, cyan.
Table 1. Summary of IC50 Values Determined from Curve
Fits of Experimentally Determined Values (determined
from Figures S4−S6, Supporting Information)a
compound IC50 [mM]
rac-3d 3.4 ± 0.3
(S)-3d 1.6 ± 0.1
(R)-3d n.a.
aReactions were run with 10 mM tryptamine 1, 50 mM
isovaleraldehyde 3a in PIPES (500 μL, 50 mM, pH 7.0, 10% v/v
DMSO) in the presence of 3d (0.01−20 mM) catalyzed by 100 μg of
purified OpSTR (∼5.5 μM) at 35 °C, 650 rpm. Velocities were
determined by following the formation of product for 3 h. Normalized
reaction rates were plotted in a semilogarithmic plot using the
SigmaPlot Standard Curves Analysis macro to determine the IC50
values. n.a.: not applicable.
Figure 3. OpSTR cocrystallized with amine 4 as ligand. The figure shows a comparison between OpSTR with amine 4 (green) bound (displayed in
blue) and OpSTR with THBC 3a (protein depicted in gray, ligand in orange). Furthermore, the orientations of 4 found in the active site of OpSTR
and in the outer coordination site at Glu6 are displayed.
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was pointing toward the enzyme surface, in different
orientations in each monomer dictated by rotation around
the side chain, suggestive of the mobility required to achieve
proximity to the imine bond for ring closure in a reactive
complex. The alicyclic nitrogen atom is located at a distance of
4.2−4.7 Å from the side chain of Glu279, in approximately the
same location as the endocyclic nitrogen of (S)-3a, with the
isobutyl group again held in a hydrophobic pocket formed by
Phe197, Trp120, and Tyr122, in a similar mode to that seen in
(S)-3a.
To investigate the influence of these active site residues
including the essential Glu276 on the reaction, variants were
generated (Table S5). The exchange of Glu276 to aspartate
yielded an active variant; however, the stereoselectivity in
reactions between 1 and 2a or 2d dropped significantly from
>98% ee and 76% ee to 92% and 8%, respectively. The same
effect was observed for variants of Trp120 with sterically less
demanding residues such as alanine, phenylalanine, and
tyrosine and for Tyr122Phe. Variant Tyr122Leu was not
active. Actually, also products with lower ee were obtained for
the variants Phe197Tyr/Trp/Leu. Thus, the variants generated
indicate that all these active side residues contribute to the
high stereoselectivity observed by the wild type enzyme for the
transformation of isovaleraldehyde 2a with 1, but they do not
give a hint for the switch of stereopreference compared to the
reaction of secologanin with 1.
To better understand the switch of stereopreference, a
combined density functional theory (DFT) and molecular
dynamics (MD) study was undertaken. The Pictet−Spengler
reaction follows a well-studied mechanism,3,17c,d,20a,21 and we
computed the free energy barrier for the analogue to confirm
the rate-determining step (Figure 4) at the M06-2X/6-311+
+G(2d,2p)-SMD // M06-2X/6-31+G(d,p)-SMD level of
theory with the water solvation model. All intermediates and
transition structures were computed from exhaustive con-
formational searches, and the lowest-energy conformations are
shown in Figure 4. In agreement with previous computational
studies,9b we found the cyclization barrier from iminium int-I
to be low and reversible (ΔG⧧ = 13.9 kcal/mol), leading to the
carbocation intermediate int-II. This is consistent with the
structural data that showed the mobility of the indole in the
binding site. We modeled the deprotonation and rear-
omatization step with a free acetate molecule to simulate the
catalytic glutamate residue. The deprotonation transition
structure TS-II has a barrier of 23.8 kcal/mol, leading directly
to the product 3a. It is well-known that the deprotonation step
is rate-determining, while the cyclization establishes the
stereochemistry of the new stereogenic center. Based on
these results, and previous studies, the cyclization step is
reversible, and the enzyme deprotonates only one of the
stereoisomeric intermediates to form the product. We chose to
model the carbocation intermediate int-II for both the
analogue and strictosidine in molecular dynamics simulations
to determine which stereoisomeric intermediate is able to
acquire the best near-attack-conformation for deprotonation.22
To understand first the stereopreference of the STR for the
natural strictosidine substrate, we performed molecular
dynamics simulations on the carbocation intermediate int-II
for (S)- and (R)-strictosidine. The intermediates were docked
into the binding pocket with Autodock Vina,23 and the best-
scoring pose was selected as the input for 500 ns of MD
simulations using Amber.24 The purpose of the MD
simulations was to determine which stereoisomeric inter-
mediate is stable in the binding pocket and best resembles the
near-attack-conformation for deprotonation. In principle, the
intermediate with the optimal near-attack-conformation
between the hydrogen (of the carbocation) and the catalytic
glutamate residue would be predicted to have a lower energy
barrier for rearomatization.
Snapshots for (S)- and (R)-strictosidine-int, the analogous
carbocation intermediates of int-II for strictosidine, are shown
in Figure 5. Figure 5A illustrates a snapshot of the carbocation
(S)-strictosidine-int in the protein pocket. The interaction
between the glutamate oxygen and hydrogen for deprotonation
is shown in blue dashed lines. The catalytic triad (tyrosine,
glutamate, and histidine) as well as residues that interact
strongly with the glucose side chain of strictosidine are shown.
Figure 5B shows a snapshot of the carbocation (R)-
strictosidine-int in the protein pocket. The interaction between
the glutamate oxygen and hydrogen for deprotonation is
shown in red dashed lines. Similarly, only the catalytic triad
and residues interacting with strictosidine are shown for clarity.
The distance between the hydrogen HA and the oxygens on
the catalytic glutamate were monitored throughout the MD
simulation, which is plotted in Figure 5C. For the (S)-
strictosidine-int carbocation, the trajectory showed that
conformations are sampled for roughly 150 ns until a highly
stable conformation is located at 175 ns, which remains for the
500 ns simulation. This is shown for one trajectory in Figure
5C by the blue line. These results are found in triplicate MD
simulations. The (R)-strictosidine-int carbocation, by contrast,
is unable to find a stable conformation in the binding pocket
and adopts a binding pose to the surface of the protein. The
red line in Figure 5C shows the H···O distance and illustrates
how the intermediate changes conformations roughly every 50
ns until the 150 ns region where the intermediate exits from
the binding pocket. These results are found in triplicate, unless
a different starting geometry is used for (R)-strictosidine-int
where the hydrogen for deprotonation is on the opposite face
of the indole ring.
In these MD simulations, the polar interactions between the
residues in Figure 5A and 5B with the strictosidine glucose unit
were observed. For the (S)-intermediate, the interactions are
maintained throughout the 500 ns of the MD simulation. In
Figure 4. Free energy profile of the Pictet−Spengler reaction between
tryptamine (1) and 2a calculated at the M06-2X/6-311++G(2d,2p)-
SMD // M06-2X/6-31+G(d,p)-SMD level of theory. Distances are in
angstroms (Å). Energies are shown in kcal/mol.
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contrast, the (R) intermediate cannot accommodate those
interactions while being in a near-attack-conformation for HA
and the glutamate oxygen. When the carbocation is flipped, a
stable conformation is found with proximal polar interactions
in the MD simulation, but deprotonation cannot occur from
this geometry. Thus, we can extrapolate that the strictosidine
synthase shows the known stereopreference because the polar
glucose unit anchors the substrate into the binding pocket by
binding to a specific region of the protein surface. This
conformation places the tryptamine unit of the carbocation
tightly in the hydrophobic region of the binding pocket. The
observed stereoisomer, (S)-strictosidine, forms because a near-
attack-conformation is highly preferred. The alternative
stereoisomer is not formed because there are insufficient
stabilizing interactions for the (R)-strictosidine intermediate
around the binding pocket to anchor the substrate to the
catalytic residue, and consequently the deprotonation is very
slow.
While the stereospecificity of strictosidine was established
with MD simulations, we continued to investigate why the
stereoselectivity switches with small aliphatic aldehydes such as
isovaleraldehyde 2a. We performed MD simulations on the
stereoisomers of the analogue substrate carbocations int-II.
Snapshots for each 500 ns MD simulation [(R)- and (S)-int-
II] are shown in Figure 6A and 6B. In both MD simulations,
the isobutyl substituent on the chiral center prefers to bind on
the inside of the binding pocket, in contrast to strictosidine
which prefers tryptamine in the binding pocket. In each
snapshot, only the catalytic triad is shown. During the 500 ns
trajectories, stable conformations are found for both stereo-
isomers within close distances to the catalytic glutamate.
However, the trajectories differ for the stereoisomeric
intermediates at the near-attack-conformation geometry. In
snapshot A, the (R)-int-II H−O distance is proximal, and the
catalytic triad is conserved with close interactions. However,
(S)-int-II, shown in snapshot B, the catalytic triad fails to form
a strong hydrogen bond consistently for a majority of the 500
ns trajectory. This occurs for a majority of the 500 ns
trajectory. The glutamate, while proximal to the substrate,
develops a C−H−O angle between 60° and 120° throughout
the MD simulation. Few snapshots reach the near-attack-
conformation and a geometry near the quantum chemical
transition structure for the (S)-analogue. The distances
between the hydrogen of the carbocations and the oxygen of
the glutamates were plotted against the C−H−O angle, which
are both required parameters for the deprotonation, shown in
Figure 6C. The green data point represents the ideal transition
structure optimized with density functional theory in Figure 4.
The data in Figure 6C show a clear trend in which (R)-int-II
often achieves a conformation close to the transition structure,
or an optimal near-attack-conformation, whereas (S)-int-II has
a poor geometry for deprotonation despite being proximal to
the catalytic residue. The difference in geometry between (R)-
int-II and (S)-int-II is the location of the isobutyl group. In
(R)-int-II, the isobutyl group moves into the area that is
occupied by the tryptamine core in strictosidine, whereas in
(S)-int-II the isobutyl group adopts a position close to the
backbone of the protein and interferes sterically with the
Figure 5. Results from MD simulation with (S)- and (R)-strictosidine-int. (A) Snapshot of MD trajectory of (S)-strictosidine-int. (B) Snapshot of
MD trajectory of (R)-strictosidine-int. (C) Plot of hydrogen (of (R/S)-strictosidine-int) to oxygen (of glutamate) distances vs time in nanoseconds
throughout the MD trajectory. The blue line represents the distance for (S)-strictosidine-int and the red line represents the distance for (R)-
strictosidine-int.
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glutamate residue, similar to that observed for the inhibiting
enantiomer in the X-ray complex with (S)-3a as well as for
amine 4. This illustrates the switch in stereopreference, as well
as the lack of stereospecificity with the smaller aldehydes.
Because both stereoisomers can reach a near-attack-conforma-
tion with a stable geometry, both stereoisomers are formed but
(R)-int-II is preferred.
Due to the suggested changed binding mode of tryptamine 1
in the reaction with 2a compared to the natural reaction with
secologanin, the KM for tryptamine 1 was determined in the
reaction between 1 and 2a and found to be 1.24 ± 0.13 mM.
This value is just about twice the value reported for the KM of
tryptamine 1 with secologanin (0.5 mM) for OpSTR.25
Literature values for the KM for the natural substrate
secologanin vary between 3.9 × 10−2 mM17c and 4 mM18e
for STR wild types, while the here determined KM for the non-
natural substrate isovaleraldehyde 2a is slightly higher at 5.36
± 0.83 mM.
It is also worth to mention that Glu276 is the active residue
in the active site in the natural reaction (tryptamine with
secologanin) as well as in the here-described inverted binding
mode. This was demonstrated by the exchange of Glu276 to
alanine, which resulted in an inactive protein.
■ CONCLUSIONS
In the (organo)catalytic Pictet−Spengler reaction investigated,
the stereochemistry-determining reaction involves the depro-
tonation of the (S)- and (R)-intermediates. The MD
simulations indicate clearly a binding mode of the natural
intermediate and the substrate in which the indole part is
pointing to the periphery of the enzyme, a conformation that
was also observed for the inhibiting enantiomer in the X-ray
complex with (S)-3a as well as for amine 4 mimicking the
iminium int-II. By contrast, the alkyl group of the aldehyde,
not bound by hydrogen binding present for secologanin,
dominates binding with unnatural aldehydes. Thus, it can be
concluded that the observed switch in stereopreference is due
to a switch of positioning of the reacting substrate parts
compared to the natural reaction of tryptamine with
secologanin. Remarkably, the same catalyst can have two
different productive binding modes for one substrate, here
tryptamine, which lead finally to opposite absolute config-
urations of the product. Furthermore, as tryptamine serves as
one reaction partner for both reactions, the one with the
natural substrate secologanin as well as the reaction with
isovaleraldehyde, the binding mode seems to be controlled by
the aldehyde and not the tryptamine part. Furthermore, the
investigations revealed that the minor enantiomer formed in
the reaction may act as an inhibitor. These insights have
profound significance for the future engineering of STRs to
ensure on the one hand that the amino acids in the appropriate
region are addressed for tuning the catalyst and on the other
hand to consider that the minor enantiomer is either not
formed or cannot bind. STRs thus present an unusual set of
considerations for the engineering of enzyme activity that may
have relevance to other systems where enzymes are required to
transform substrates very different from those accepted in the
native reaction.
Figure 6. Results from MD simulation with (R)- and (S)-int-II. (A) Snapshot of MD trajectory of (R)-int-II. (B) Snapshot of MD trajectory of
(S)-int-II. (C) Plot of hydrogen (of int-II) to oxygen (of glutamate) distances vs C−H−O angles throughout the MD trajectory, with the
transition state geometry shown in green. The blue data points are results from the MD trajectory with (R)-int-II, and the red data points are
results from the MD trajectory with (S)-int-II.
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Phenyl-alanin und Tyrosin. Ber. Dtsch. Chem. Ges. 1911, 44, 2030−
2036.
(4) (a) Cox, E. D.; Hamaker, L. K.; Li, J.; Yu, P.; Czerwinski, K. M.;
Deng, L.; Bennett, D. W.; Cook, J. M.; Watson, W. H.; Krawiec, M.
Enantiospecific formation of trans 1,3-Disubstituted Tetrahydro-β-
carbolines by the Pictet−Spengler reaction and Conversion of Cis
Diastereomers into their trans counterparts by Scission of the C-1/N-
2 Bond. J. Org. Chem. 1997, 62, 44−61. (b) Bailey, P. D.; Moore, M.
H.; Morgan, K. M.; Smith, D. I.; Vernon, J. M. Enhancing the yield
and diastereoselectivity of the Pictet−Spengler reaction: A highly
efficient route to Cis-1,3-disubstituted tetrahydro-β-carbolines.
Tetrahedron Lett. 1994, 35, 3587−3588. (c) Alberch, L.; et al. The
cis-Specific Pictet−Spengler Reaction. Eur. J. Org. Chem. 2004, 2004,
1887−1890. (d) Bailey, P. D.; Beard, M. A.; Phillips, T. R.
Unexpected cis selectivity in the Pictet−Spengler reaction. Tetrahe-
dron Lett. 2009, 50, 3645−3647.
(5) Ducrot, P.; Rabhi, C.; Thal, C. Synthesis of tetrahydro-β-
carbolines and studies of the pictet−spengler reaction. Tetrahedron
2000, 56, 2683−2692.
(6) (a) Kawate, T.; Yamanaka, M.; Nakagawa, M. Chiral auxiliary
approach to the asymmetric Pictet−Spengler reaction of tryptamines.
Heterocycles 1999, 50, 1033−1039. (b) Soe, T.; Kawate, T.; Fukui, N.;
Nakagawa, M. Asymmetric Pictet−Spengler reaction with chiral-N-(β-
3-indoly) ethyl-1-methylbenzylamine. Tetrahedron Lett. 1995, 36,
1857−1860. (c) Gremmen, C.; Willemse, B.; Wanner, M. J.; Koomen,
G.-J. Enantiopure Tetrahydro-β-carbolines via Pictet−Spengler
Reactions with N-Sulfinyl Tryptamines. Org. Lett. 2000, 2, 1955−
1958. (d) Waldmann, H.; Schmidt, G.; Henke, H.; Burkard, M.
Asymmetric Pictet−Spengler reactions employing N,N-phthaloyl
amino acids as chiral auxiliary groups. Angew. Chem., Int. Ed. Engl.
1995, 34, 2402−2403.
(7) (a) Seayad, J.; Seayad, A. M.; List, B. Catalytic Asymmetric
Pictet−Spengler Reaction. J. Am. Chem. Soc. 2006, 128, 1086−1087.
(b) Wanner, M. J.; van der Haas, R. N.; de Cuba, K. R.; van
Maarseveen, J. H.; Hiemstra, H. Catalytic asymmetric Pictet−
Spengler reactions via sulfenyliminium ions. Angew. Chem., Int. Ed.
2007, 46, 7485−7487. (c) Sewgobind, N. V.; Wanner, M. J.;
Ingemann, S.; de Gelder, R.; van Maarseveen, J. H.; Hiemstra, H.
Enantioselective Binol-phosphoric acid catalyzed Pictet−Spengler
reactions of N-benzyltryptamine. J. Org. Chem. 2008, 73, 6405−
6408. (d) Muratore, M. E.; Holloway, C. A.; Pilling, A. W.; Storer, R.
I.; Trevitt, G.; Dixon, D. J. Enantioselective Brønsted acid-catalyzed
N-acyliminium cyclization cascades. J. Am. Chem. Soc. 2009, 131,
10796−10797. (e) Holloway, C. A.; Muratore, M. E.; Storer, R. l.;
Dixon, D. J. Direct Enantioselective Brønsted Acid Catalyzed N-
Acyliminium Cyclization Cascades of Tryptamines and Ketoacids.
Org. Lett. 2010, 12, 4720−4723. (f) Wang, S. G.; Xia, Z. L.; Xu, R. Q.;
Liu, X. J.; Zheng, C.; You, S. L. Construction of Chiral Tetrahydro-β-
Carbolines: Asymmetric Pictet−Spengler Reaction of Indolyl
Dihydropyridines. Angew. Chem., Int. Ed. 2017, 56, 7440−7443.
(8) (a) Ishihara, K.; Miyata, M.; Hattori, K.; Tada, T.; Yamamoto,
H. A new chiral BLA promoter for asymmetric aza Diels-Alder and
Aldol-type reactions of imines. J. Am. Chem. Soc. 1994, 116, 10520−
10524. (b) Yamada, H.; Kawate, T.; Matsumizu, M.; Nishida, A.;
Yamaguchi, K.; Nakagawa, M. Chiral Lewis Acid-Mediated
Enantioselective Pictet−Spengler Reaction of N b-Hydroxytryptamine
with Aldehydes. J. Org. Chem. 1998, 63, 6348−6354. (c) Bou-
Hamdan, F. R.; Leighton, J. L. Highly Enantioselective Pictet−
Spengler Reactions with α-Ketoamide-Derived Ketimines: Access to
an Unusual Class of Quaternary α-Amino Amides. Angew. Chem., Int.
Ed. 2009, 48, 2403−2406.
(9) (a) Taylor, M. S.; Jacobsen, E. N. Highly enantioselective
catalytic acyl-Pictet−Spengler reactions. J. Am. Chem. Soc. 2004, 126,
10558−10559. (b) Klausen, R. S.; Kennedy, C. R.; Hyde, A. M.;
Journal of the American Chemical Society pubs.acs.org/JACS Article
https://dx.doi.org/10.1021/jacs.9b08704
J. Am. Chem. Soc. 2020, 142, 792−800
798
Jacobsen, E. N. Chiral Thioureas Promote Enantioselective Pictet−
Spengler Cyclization by Stabilizing Every Intermediate and Transition
State in the Carboxylic Acid-Catalyzed Reaction. J. Am. Chem. Soc.
2017, 139, 12299−12309. (c) Raheem, I. T.; Thiara, P. S.; Peterson,
E. A.; Jacobsen, E. N. Enantioselective Pictet−Spengler-type
cyclizations of hydroxylactams: H-bond donor catalysis by anion
binding. J. Am. Chem. Soc. 2007, 129, 13404−13405. (d) Mergott, D.
J.; Zuend, S. J.; Jacobsen, E. N. Catalytic asymmetric total synthesis of
(+)-yohimbine. Org. Lett. 2008, 10, 745−748.
(10) Stockigt, J.; Zenk, M. H. Strictosidine (isovincoside): the key
intermediate in the biosynthesis of monoterpenoid indole alkaloids. J.
Chem. Soc., Chem. Commun. 1977, 646−648.
(11) (a) Rueffer, M.; El-Shagi, H.; Nagakura, N.; Zenk, M. H. (S)-
norlaudanosoline synthase: The first enzyme in the benzylisoquino-
line biosynthetic pathway. FEBS Lett. 1981, 129, 5−9. (b) Samanani,
N.; Facchini, P. J. Purification and Characterization of Norcoclaurine
Synthase: the First Committed Enzyme in Benzylisoquinoline
Alkaloid Biosynthesis in Plants. J. Biol. Chem. 2002, 277, 33878−
33883. (c) Luk, L. Y. P.; Bunn, S.; Liscombe, D. K.; Facchini, P. J.;
Tanner, M. E. Mechanistic Studies on Norcoclaurine Synthase of
Benzylisoquinoline Alkaloid Biosynthesis: An Enzymatic Pictet−
Spengler Reaction. Biochemistry 2007, 46, 10153−10161. (d) Ilari,
A.; Franceschini, S.; Bonamore, A.; Arenghi, F.; Botta, B.; Macone, A.;
Pasquo, A.; Bellucci, L.; Boffi, A. Structural Basis of Enzymatic (S)-
Norcoclaurine Biosynthesis. J. Biol. Chem. 2009, 284, 897−904.
(e) Lichman, B. R.; Gershater, M. C.; Lamming, E. D.; Pesnot, T.;
Sula, A.; Keep, N. H.; Hailes, H. C.; Ward, J. M. ‘Dopamine-first’
mechanism enables the rational engineering of the norcoclaurine
synthase aldehyde activity profile. FEBS J. 2015, 282, 1137−1151.
(f) Pesnot, T.; Gershater, M. C.; Ward, J. M.; Hailes, H. C. The
Catalytic Potential of Coptis japonica NCS2 Revealed − Develop-
ment and Utilisation of a Fluorescamine-Based Assay. Adv. Synth.
Catal. 2012, 354, 2997−3008. (g) Lechner, H.; Soriano, P.; Poschner,
R.; Hailes, H. C.; Ward, J. M.; Kroutil, W. Library of Norcoclaurine
Synthases and Their Immobilization for Biocatalytic Transformations.
Biotechnol. J. 2018, 13, 1700542.
(12) (a) De-Eknamkul, W.; Ounaroon, A.; Tanahashi, T.; Kutchan,
T. M.; Zenk, M. H. Enzymatic condensation of dopamine and
secologanin by cell-free extracts of Alangium lamarckii. Phytochemistry
1997, 45, 477−484. (b) De-Eknamkul, W.; Suttipanta, N.; Kutchan,
T. M. Purification and characterization of deacetylipecoside synthase
from Alangium lamarckii Thw. Phytochemistry 2000, 55, 177−181.
(13) (a) Koketsu, K.; Minami, A.; Watanabe, K.; Oguri, H.; Oikawa,
H. Pictet−Spenglerase involved in tetrahydroisoquinoline antibiotic
biosynthesis. Curr. Opin. Chem. Biol. 2012, 16, 142−149. (b) Koketsu,
K.; Watanabe, K.; Suda, H.; Oguri, H.; Oikawa, H. Reconstruction of
the saframycin core scaffold defines dual Pictet−Spengler mecha-
nisms. Nat. Chem. Biol. 2010, 6, 408.
(14) (a) Mori, T.; Hoshino, S.; Sahashi, S.; Wakimoto, T.; Matsui,
T.; Morita, H.; Abe, I. Structural Basis for β-Carboline Alkaloid
Production by the Microbial Homodimeric Enzyme McbB. Chem.
Biol. 2015, 22, 898−906. (b) Chen, Q.; Ji, C.; Song, Y.; Huang, H.;
Ma, J.; Tian, X.; Ju, J. Discovery of McbB, an Enzyme Catalyzing the
β-Carboline Skeleton Construction in the Marinacarboline Biosyn-
thetic Pathway. Angew. Chem., Int. Ed. 2013, 52, 9980−9984.
(15) Chen, Q.; Zhang, S.; Xie, Y. Characterization of a new
microbial Pictet−Spenglerase NscbB affording the β-carboline
skeletons from Nocardiopsis synnemataformans DSM 44143. J.
Biotechnol. 2018, 281, 137−143.
(16) Brown, R. T.; Leonard, J.; Sleigh, S. K. The role of strictosidine
in monoterpenoid indole alkaloid biosynthesis. Phytochemistry 1978,
17, 899−900.
(17) (a) Ma, X.; Koepke, J.; Fritzsch, G.; Diem, R.; Kutchan, T. M.;
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A.; Panjikar, S.; Trout, B. L.; Stöckigt, J.; Peters, B.; O’Connor, S. E.
Strictosidine synthase: Mechanism of a Pictet−spengler catalyzing
enzyme. J. Am. Chem. Soc. 2008, 130, 710−723. (e) Stöckigt, J.;
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